October 24, 2025

Synbiotic Supplement Reduced Multiple Inflammatory Proteins

Butyrate rise corresponded with lower IL-6 during 6-week synbiotic supplementation.

Conexiant

October 24, 2025

A Smarter Clock for Biological Age 

Combining transcriptomic and glycomic data, a next-generation biological clock could help detect age-related disease risk long before symptoms appear 

The Analytical Scientist

October 24, 2025

Hedgehogs, Seaweed, and the Future of Cell Logistics

How biology, sustainability, and a nod to the African pygmy hedgehog are reshaping how we move living cells around the world – and beyond.

The Medicine Maker

October 24, 2025

Innovation at Scale: A Conversation with Agilent’s New CTO

We speak with August Specht, Chief Technology Officer at Agilent, about the opportunities and risks of AI, the promise of multimodal data, and building a more connected and sustainable future for analytical science

The Analytical Scientist

October 23, 2025

Nutritional IBD screening tools ranked

Single-center cohort finds MIRT most sensitive at predicting malnutrition or low Fat-Free Mass Index within six months in patients in remission with IBD; SaskIBD-NR shows the highest accuracy for GLIM-defined malnutrition and for low Fat-Free Mass Index.

Conexiant

October 22, 2025

AGA releases updated guideline on endoscopic surveillance of Barrett’s esophagus

A panel came to a consensus on eight recommendations regarding the role of endoscopic surveillance in patients with Barrett’s esophagus.

Conexiant

October 22, 2025

Medical Oddities: Oxygen Via Rectum?

Oxygen from below, coffee for gout, and hugs with hidden motives—just another week.

Conexiant

October 22, 2025

Do GLP-1RAs Differ in Cardiometabolic Protection?

Researchers found that liraglutide and semaglutide offer similar cardiovascular and kidney benefits in type 2 diabetes.

Conexiant

October 21, 2025

Impact of HER2-Receptor Status in mCRC Treated With Chemotherapy Plus Bevacizumab or Anti-EGFR Agents

In an analysis reported in the Journal of Clinical Oncology, Germani et al identified the impact of HER2 status in patients with metastatic colorectal cancer (mCRC) receiving chemotherapy plus either ...

The ASCO Post